NSE: BIOCON | BSE: 532523

Mid-range Performer

Download real time

341.60 2.20 (0.65%)

26.73% Gain from 52W Low

1.5M NSE+BSE Volume

NSE 19 May, 2025 3:31 PM (IST)

41,012.5

Market Cap

Market Leader

1.2

Beta 1Year

High Volatility

Biocon Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Biocon Ltd. from all sources in a single place.

Load latest

21 Mar 2024

341.60

0.65%

Stock to sell today: Biocon (247)

Business Line

The chart shows that the price could drop to 240 in a day or two

Biocon Ltd. has an average target of 389.25 from 4 brokers.

16 Mar 2024

341.60

0.65%

Corp. Note

BIOCON LTD. - 532523 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate …

BSE India

Details of the share certificate which has been reported as lost/misplaced from the custody of the shareholder.

14 Mar 2024

341.60

0.65%

Company Update

BIOCON LTD. - 532523 - Announcement Under Regulation 30

BSE India

Updated list of KMPs authorized to determine materiality of an event or information and make necessary disclosures to the Stock Exchange(s).

14 Mar 2024

341.60

0.65%

Company Update

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

BSE India

Resignation of Mr. Indranil Sen, Chief Financial Officer of the Company w.e.f. March 14, 2024.

14 Mar 2024

341.60

0.65%

Biocon Shares Rise On Rs 1,242 Crore Collaboration With Eris Lifesciences

NDTV Profit

The collaboration will help extend its existing partnership with Eris for Biocon's Nephrology and Dermatology business.

Axis Direct decreased Buy price target of Biocon Ltd. to 351.0 on 03 May, 2025.

14 Mar 2024

341.60

0.65%

Company Update

BIOCON LTD. - 532523 - Announcement Under Regulation 30

BSE India

Biocon Biologics Limited, subsidiary of the company, has approved sale of its business in relation to its branded formulations in India to Eris Lifesciences Limited, on a ''slump sale'' basis.

04 Mar 2024

341.60

0.65%

Company Update

BIOCON LTD. - 532523 - Announcement Under Regulation 30 (LODR)

BSE India

Appointment of Senior Management Personnel.

04 Mar 2024

341.60

0.65%

Company Update

BIOCON LTD. - 532523 - Announcement Under Regulation 30 (LODR)

BSE India

Company Statement

01 Mar 2024

341.60

0.65%

Biocon shares gain on licence deal with Janssen, JJ for US markets

Moneycontrol

Biocon Share Price | In an another development, the company's subsidiary received observations from US Food and Drug Administration (USFDA).

Axis Direct decreased Buy price target of Biocon Ltd. to 351.0 on 03 May, 2025.

29 Feb 2024

341.60

0.65%

Company Update

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pls find enclosed copy of Press Release

Is Biocon Ltd. worth buying?

715 Votes:

Buy 75.1%

Sell 16.36%

Hold 8.53%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >